In vitro and in vivo immunosuppressive potential of thalidomide and its derivative, N-hydroxythalidomide, alone and in combination with cyclosporin A
- 31 May 1997
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 19 (5), 289-296
- https://doi.org/10.1016/s0192-0561(97)00067-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Thalidomide as an Anti-TNF-α Inhibitor: Implications for Clinical UseClinical Immunology and Immunopathology, 1996
- Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomideChirality, 1995
- Thalidomide and the immune system 3. simultaneous up- and down-regulation of different integrin receptors on human white blood cellsLife Sciences, 1994
- Embryotoxic effects of thalidomide derivatives in the non-human primateCallithrix jacchusArchives of Toxicology, 1994
- Thalidomide derivatives and the immune system. I. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset bloodArchives of Toxicology, 1993
- Cellular Immune Effects of Thalidomide in Actinic PrurigoInternational Journal of Dermatology, 1992
- Self superantigens?Cell, 1990
- Treatment of severe colitis in Behcet's syndrome with thalidomide (CG‐217)Journal of Internal Medicine, 1990
- Studies on the anti-inflammatory properties of thalidomide: Effects on polymorphonuclear leukocytes and monocytesJournal of the American Academy of Dermatology, 1984
- Thalidomide a promising new treatment for rheumatoid arthritisArthritis & Rheumatism, 1984